CYS:CLL Statistics
Total Valuation
CYS:CLL has a market cap or net worth of EUR 1.30 million. The enterprise value is 96,864.
| Market Cap | 1.30M |
| Enterprise Value | 96,864 |
Important Dates
The last earnings date was Thursday, September 25, 2025.
| Earnings Date | Sep 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CYS:CLL has 288.14 million shares outstanding.
| Current Share Class | 288.14M |
| Shares Outstanding | 288.14M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.66% |
| Owned by Institutions (%) | n/a |
| Float | 180.45M |
Valuation Ratios
The trailing PE ratio is 0.74.
| PE Ratio | 0.74 |
| Forward PE | n/a |
| PS Ratio | 0.75 |
| PB Ratio | 0.30 |
| P/TBV Ratio | 0.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.06 |
| EV / Sales | 0.06 |
| EV / EBITDA | 0.06 |
| EV / EBIT | 0.06 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.21, with a Debt / Equity ratio of 0.13.
| Current Ratio | 14.21 |
| Quick Ratio | 14.09 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | n/a |
| Interest Coverage | 48.69 |
Financial Efficiency
Return on equity (ROE) is 50.39% and return on invested capital (ROIC) is 21.66%.
| Return on Equity (ROE) | 50.39% |
| Return on Assets (ROA) | 21.22% |
| Return on Invested Capital (ROIC) | 21.66% |
| Return on Capital Employed (ROCE) | 29.02% |
| Revenue Per Employee | 34,737 |
| Profits Per Employee | 34,828 |
| Employee Count | 50 |
| Asset Turnover | 0.42 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CYS:CLL has paid 15,834 in taxes.
| Income Tax | 15,834 |
| Effective Tax Rate | 0.90% |
Stock Price Statistics
The stock price has increased by +80.00% in the last 52 weeks. The beta is 0.22, so CYS:CLL's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | +80.00% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 48.87 |
| Average Volume (20 Days) | 45,094 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CYS:CLL had revenue of EUR 1.74 million and earned 1.74 million in profits. Earnings per share was 0.01.
| Revenue | 1.74M |
| Gross Profit | 1.74M |
| Operating Income | 1.40M |
| Pretax Income | 1.76M |
| Net Income | 1.74M |
| EBITDA | 1.41M |
| EBIT | 1.40M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 1.78 million in cash and 580,635 in debt, giving a net cash position of 1.20 million or 0.00 per share.
| Cash & Cash Equivalents | 1.78M |
| Total Debt | 580,635 |
| Net Cash | 1.20M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 4.32M |
| Book Value Per Share | 0.02 |
| Working Capital | 1.68M |
Cash Flow
| Operating Cash Flow | -541,468 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 80.88% and 100.26%.
| Gross Margin | 100.00% |
| Operating Margin | 80.88% |
| Pretax Margin | 101.17% |
| Profit Margin | 100.26% |
| EBITDA Margin | 80.90% |
| EBIT Margin | 80.88% |
| FCF Margin | n/a |
Dividends & Yields
CYS:CLL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 134.30% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CYS:CLL has an Altman Z-Score of 1.27 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.27 |
| Piotroski F-Score | 4 |